Fig. 1From: Effectiveness and safety of azvudine versus nirmatrelvir/ritonavir in hospitalized patients with COVID-19The love plot illustrated the balance of covariates before and after 1:3 PSM between nirmatrelvir/ritonavir and azvudineBack to article page